MedPath
NMPA Approval

Osalmid Tablets

国药准字H44021486

October 10, 2024

Drug Information

柳胺酚片

片剂

0.25g

化学药品

October 10, 2024

Company Information

Applicant Company

广州市白云区同和街云祥路88号

Manufacturing Company

广州市白云区同和街云祥路88号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

柳胺酚片 - NMPA 批准文号 | MedPath